Home

Medicamen Biotech Ltd 52 Week Low

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

YEARLOW

₹ 356.75

Last updated on: Feb 21, 2025

Key Highlights

  • The 52 Week Low of Medicamen Biotech Ltd is ₹ 356.75 as of 21 Feb 25 .

Company Fundamentals for Medicamen Biotech Ltd

Market Price of Medicamen Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025547.25
20 Feb 2025526.95
19 Feb 2025498.35
18 Feb 2025466.35
17 Feb 2025449.8
14 Feb 2025430.65
13 Feb 2025469.6
12 Feb 2025466.55
11 Feb 2025472
10 Feb 2025496.85

Asset Value vs Market Value of Medicamen Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Medicamen Biotech Ltd

No data available

* All values are in crore

Medicamen Biotech Ltd News Hub

Medicamen Biotech consolidated net profit declines 67.70% in the June 2024 quarter

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as a

Read more

13 Aug 24

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po

Read more

12 Aug 24

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be held on 26

Read more

13 Sept 24

Medicamen Biotech declare Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024 P

Read more

08 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Medicamen Biotech Ltd

Why is it important to track the 52-week low of Medicamen Biotech Ltd stocks?

Investors should monitor the 52-week low of Medicamen Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Medicamen Biotech Ltd stocks hitting a 52-week low?

Factors leading to Medicamen Biotech Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Medicamen Biotech Ltd stocks when they hit a 52-week low?

Buying Medicamen Biotech Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Medicamen Biotech Ltd stocks?

Investors should monitor the 52-week low of Medicamen Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Medicamen Biotech Ltd stock at their 52-week low?

An investor can analyze the reasons for the Medicamen Biotech Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Medicamen Biotech Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Medicamen Biotech Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Medicamen Biotech Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions